These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18598111)

  • 1. New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools.
    Meuwis MA; Fillet M; Chapelle JP; Malaise M; Louis E; Merville MP
    Expert Rev Mol Diagn; 2008 May; 8(3):327-37. PubMed ID: 18598111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients.
    Nanni P; Levander F; Roda G; Caponi A; James P; Roda A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3127-36. PubMed ID: 19683480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostics of inflammatory bowel disease.
    Nikolaus S; Schreiber S
    Gastroenterology; 2007 Nov; 133(5):1670-89. PubMed ID: 17983810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine.
    Collins CD; Purohit S; Podolsky RH; Zhao HS; Schatz D; Eckenrode SE; Yang P; Hopkins D; Muir A; Hoffman M; McIndoe RA; Rewers M; She JX
    Vascul Pharmacol; 2006 Nov; 45(5):258-67. PubMed ID: 17030152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling approaches for identifying novel biomarkers.
    Bailey WJ; Ulrich R
    Expert Opin Drug Saf; 2004 Mar; 3(2):137-51. PubMed ID: 15006720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced detectability in proteome studies.
    Sriyam S; Sinchaikul S; Tantipaiboonwong P; Tzao C; Phutrakul S; Chen ST
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):91-104. PubMed ID: 17140866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics approaches in clinical proteomics.
    Fung ET; Weinberger SR; Gavin E; Zhang F
    Expert Rev Proteomics; 2005 Dec; 2(6):847-62. PubMed ID: 16307515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for inflammatory bowel disease.
    Foley KF; Kao P
    Clin Lab Sci; 2007; 20(2):84-8. PubMed ID: 17557707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.
    Jones J; Loftus EV; Panaccione R; Chen LS; Peterson S; McConnell J; Baudhuin L; Hanson K; Feagan BG; Harmsen SW; Zinsmeister AR; Helou E; Sandborn WJ
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1218-24. PubMed ID: 18799360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomic approaches in biomarker discovery of inflammatory bowel disease.
    Han NY; Kim EH; Choi J; Lee H; Hahm KB
    J Dig Dis; 2012 Oct; 13(10):497-503. PubMed ID: 22988922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics.
    Ferrer-Alcón M; Arteta D; Guerrero MJ; Fernandez-Orth D; Simón L; Martinez A
    Toxicol Lett; 2009 Apr; 186(1):45-51. PubMed ID: 19022361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of capsule endoscopy in patients with suspected Crohn's disease.
    Tukey M; Pleskow D; Legnani P; Cheifetz AS; Moss AC
    Am J Gastroenterol; 2009 Nov; 104(11):2734-9. PubMed ID: 19584828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbes in Crohn's disease: getting to know you better?
    Murphy SJ; Ullman TA; Abreu MT
    Am J Gastroenterol; 2008 Feb; 103(2):397-8. PubMed ID: 18289202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein and small molecule microarrays: powerful tools for high-throughput proteomics.
    Uttamchandani M; Wang J; Yao SQ
    Mol Biosyst; 2006 Jan; 2(1):58-68. PubMed ID: 16880923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling in drug discovery and development.
    Stratowa C; Wilgenbus KK
    Curr Opin Mol Ther; 1999 Dec; 1(6):671-9. PubMed ID: 19629863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1H NMR based metabolic profiling in Crohn's disease by random forest methodology.
    Fathi F; Majari-Kasmaee L; Mani-Varnosfaderani A; Kyani A; Rostami-Nejad M; Sohrabzadeh K; Naderi N; Zali MR; Rezaei-Tavirani M; Tafazzoli M; Arefi-Oskouie A
    Magn Reson Chem; 2014 Jul; 52(7):370-6. PubMed ID: 24757065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of human populations for early markers of cadmium toxicity: a review.
    Fowler BA
    Toxicol Appl Pharmacol; 2009 Aug; 238(3):294-300. PubMed ID: 19433102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of DNA microarray in disease diagnostics.
    Yoo SM; Choi JH; Lee SY; Yoo NC
    J Microbiol Biotechnol; 2009 Jul; 19(7):635-46. PubMed ID: 19652509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.